Reaction

Septic Embolus reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 823 reports · 31 co-occurring drugs

As of the last recalculation, Septic Embolus appears in 823 FAERS reports alongside 31 co-occurring drug terms. The strongest observed disproportionality signal is POSACONAZOLE DELAYED-RELEASE (PRR 69.2).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Posaconazole Delayed-Release2969.269.4
Amphotericin B3267.267.3
Cefepime3666.466.5
Cefepime Hydrochloride3760.860.9
Posaconazole2946.746.8
Ganciclovir Sodium1946.546.5
Voriconazole Injection3643.843.9
Ganciclovir1640.340.4
Micafungin Sodium1236.336.4
Gentamicin1835.635.6
Voriconazole4035.035.0
Gentamicin Sulfate2134.534.5
Vancomycin Hydrochloride7933.433.5
Vancomycin6832.332.4
Anti-Thymocyte Globulin (Rabbit)1031.731.8
Daptomycin1027.727.8
Itraconazole1226.426.4
Busulfan1524.524.6
Rifampin1322.922.9
Cytarabine4720.920.9
Mycophenilic Acid1619.919.9
Cefazolin719.619.6
Pegaspargase918.818.8
Ceftriaxone Sodium2517.017.0
Meropenem2117.017.0
Ceftriaxone2116.616.6
Vincristine Sulfate1614.114.1
Fludarabine Phosphate2013.213.2
Azacitidine1412.112.1
Fentanyl Citrate811.411.4
Azacitidine For811.211.2

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.